Authors:
Bergan, RC
Waggle, DH
Carter, SK
Horak, I
Slichenmyer, W
Meyers, M
Citation: Rc. Bergan et al., Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer, UROLOGY, 57(4A), 2001, pp. 77-80
Authors:
Meyers, M
Wagner, MW
Hwang, HS
Kinsella, TJ
Boothman, DA
Citation: M. Meyers et al., Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediatedcell death and cell cycle responses, CANCER RES, 61(13), 2001, pp. 5193-5201
Authors:
Chiu, SM
Davis, TW
Meyers, M
Ahmad, N
Mukhtar, H
Separovic, D
Citation: Sm. Chiu et al., Phthalocyanine 4-photodynamic therapy induces ceramide generation and apoptosis in acid sphingomyelinase-deficient mouse embryonic fibroblasts, INT J ONCOL, 16(2), 2000, pp. 423-427
Authors:
von Gottberg, A
van Nierop, W
Duse, A
Kassel, M
McCarthy, K
Brink, A
Meyers, M
Smego, R
Koornhof, H
Citation: A. Von Gottberg et al., Epidemiology of glycopeptide-resistant enterococci colonizing high-risk patients in hospitals in Johannesburg, Republic of South Africa, J CLIN MICR, 38(2), 2000, pp. 905-909
Authors:
Lewis, JJ
Janetzki, S
Schaed, S
Panageas, KS
Wang, SQ
Williams, L
Meyers, M
Butterworth, L
Livingston, PO
Chapman, PB
Houghton, AN
Citation: Jj. Lewis et al., Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide, INT J CANC, 87(3), 2000, pp. 391-398
Authors:
Ragupathi, G
Meyers, M
Adluri, S
Howard, L
Musselli, C
Livingston, PO
Citation: G. Ragupathi et al., Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21, INT J CANC, 85(5), 2000, pp. 659-666
Authors:
Yao, TJ
Meyers, M
Livingston, PO
Houghton, AN
Chapman, PB
Citation: Tj. Yao et al., Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plusBCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies, CLIN CANC R, 5(1), 1999, pp. 77-81
Authors:
Berry, SE
Garces, C
Hwang, HS
Kunugi, K
Meyers, M
Davis, TW
Boothman, DA
Kinsella, TJ
Citation: Se. Berry et al., The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells, CANCER RES, 59(8), 1999, pp. 1840-1845